Ballooning demand for the diabetes drugs Ozempic has triggered main shortages and the Therapeutic Goods Administration (TGA) has restricted entry for Australians.
Doctors at the moment are being suggested to not prescribe new sufferers Ozempic until there aren’t any appropriate alternate options.
They are additionally suggested to modify sufferers already receiving the drug to another, if potential, as provides run low.
“Supplies should be conserved for patients who are stabilised on Ozempic who have no other treatment options,” the TGA mentioned.
The scarcity is anticipated to final for the rest of this yr and all through 2024, based on the drug’s producer Novo Nordisk.
The firm mentioned it was persevering with to extend manufacturing capability however it could take time to construct provide ranges to fulfill world and native demand.
Ozempic is a model of the favored kind 2 diabetes drug semaglutide that has gained recognition on-line for its use as a weight reduction remedy.
While the drug has turn out to be more and more widespread as a weight reduction remedy, the TGA says it ought to solely be prescribed for sufferers with kind 2 diabetes.
Ozempic, which has the side-effect of suppressing urge for food, sprung into the general public eye as a weight reduction remedy following heavy social media promotion.
Source: www.9news.com.au
